Drug intelligence / Profile preview

TECHBONE-MAX

Development stage
Unknown
Lead developer
Varmed Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

TECHBONE-MAX is a multi-ingredient nutritional supplement developed by Varmed Pharma Private Limited. It is formulated as a softgel capsule containing calcium carbonate, calcitriol (the active form of vitamin D3), methylcobalamin (vitamin B12), folic acid, boron, and omega-3 fatty acids (including EPA and DHA). The supplement is primarily indicated for the management of bone health conditions such as osteopenia and osteoporosis, as well as for addressing nutritional deficiencies. Its mechanism of action involves providing elemental calcium for bone mineralization, enhancing intestinal calcium absorption via calcitriol's action on the Vitamin D receptor, supporting nerve health and cellular function through B-vitamin replacement, and providing anti-inflammatory benefits via omega-3 fatty acids. It is marketed in India as an approved formulation for bone-related disorders and overall well-being.

Brand names
TECHBONE-MAX
Other names
TECHBONE MAX
02

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on TECHBONE-MAX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TECHBONE-MAX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call